| Allied Op Inc | |
| 813 E Gate Dr, Ste A, Mount Laurel, New Jersey 08054 | |
| (856) 273-6400 |
| Name | Allied Op Inc |
|---|---|
| Organization Name | Jack Gold Surgical Appliances, Inc. |
| Location | 813 E Gate Dr, Ste A, Mount Laurel, New Jersey 08054 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (856) 273-6400 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
It was a memorable place to have an "aha" moment about aging. Peter Sperry had taken his 82-year-old father, who'd had a stroke and used a wheelchair, to Disney World. Just after they'd made their way through the Pirates of the Caribbean ride, nature called. Sperry took his father to the bathroom where, with difficulty, he changed the older man's diaper.
Genentech, a member of the Roche Group, today announced the results of the Phase II study TDM4450g in people with previously untreated HER2-positive metastatic breast cancer.
Although the overall rate of admissions to substance abuse treatment in the U.S. remained stable between 1998 and 2008, at about 770 admissions for every 100,000 persons in the population, a new study shows striking changes and variations in admission rates by region. For example, the rate of admissions for alcohol as the primary drug has declined by 15 percent nationally. However admission rates for alcohol in West North Central states (Ark., Iowa, Kan., Minn., Mo., N.D., Neb. and S.D.) remained the same.
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for its fourth quarter and fiscal year ended June 30, 2010. The Company's annual report on Form 10-K has been filed with the U.S. Securities and Exchange Commission and is available on the Company's website.
› Verified 6 days ago
| NPI Number | 1285638981 |
| Organization Name | JACK GOLD SURGICAL APPLIANCES, INC. |
| Doing Business As | ALLIEDOP, INC |
| Type | Prosthetic/Orthotic Supplier |
| Address | 813 E Gate Dr, Suite A, Mount Laurel, NJ 08054 |
| Phone Number | 856-243-6400 |
News Archive
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
It was a memorable place to have an "aha" moment about aging. Peter Sperry had taken his 82-year-old father, who'd had a stroke and used a wheelchair, to Disney World. Just after they'd made their way through the Pirates of the Caribbean ride, nature called. Sperry took his father to the bathroom where, with difficulty, he changed the older man's diaper.
Genentech, a member of the Roche Group, today announced the results of the Phase II study TDM4450g in people with previously untreated HER2-positive metastatic breast cancer.
Although the overall rate of admissions to substance abuse treatment in the U.S. remained stable between 1998 and 2008, at about 770 admissions for every 100,000 persons in the population, a new study shows striking changes and variations in admission rates by region. For example, the rate of admissions for alcohol as the primary drug has declined by 15 percent nationally. However admission rates for alcohol in West North Central states (Ark., Iowa, Kan., Minn., Mo., N.D., Neb. and S.D.) remained the same.
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for its fourth quarter and fiscal year ended June 30, 2010. The Company's annual report on Form 10-K has been filed with the U.S. Securities and Exchange Commission and is available on the Company's website.
› Verified 6 days ago
News Archive
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
It was a memorable place to have an "aha" moment about aging. Peter Sperry had taken his 82-year-old father, who'd had a stroke and used a wheelchair, to Disney World. Just after they'd made their way through the Pirates of the Caribbean ride, nature called. Sperry took his father to the bathroom where, with difficulty, he changed the older man's diaper.
Genentech, a member of the Roche Group, today announced the results of the Phase II study TDM4450g in people with previously untreated HER2-positive metastatic breast cancer.
Although the overall rate of admissions to substance abuse treatment in the U.S. remained stable between 1998 and 2008, at about 770 admissions for every 100,000 persons in the population, a new study shows striking changes and variations in admission rates by region. For example, the rate of admissions for alcohol as the primary drug has declined by 15 percent nationally. However admission rates for alcohol in West North Central states (Ark., Iowa, Kan., Minn., Mo., N.D., Neb. and S.D.) remained the same.
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for its fourth quarter and fiscal year ended June 30, 2010. The Company's annual report on Form 10-K has been filed with the U.S. Securities and Exchange Commission and is available on the Company's website.
› Verified 6 days ago
Breg, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3001 Irwin Rd, Mount Laurel, New Jersey 08054 Phone: (856) 316-1045 | |
Shoprite Pharmacy Of Ark Rd 515 Type: Community/Retail Pharmacy Location: 127 Ark Rd, Mount Laurel, New Jersey 08054 Phone: (856) 359-2181 | |
Allied Op Inc Type: Prosthetic/Orthotic Supplier Location: 813 E Gate Dr, Mount Laurel, New Jersey 08054 Phone: (856) 273-6400 | |
Medeast Post Op & Surgical Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3001 Irwin Rd, Mount Laurel, New Jersey 08054 Phone: (856) 829-2030 | |
Cvs Pharmacy #00668 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3110 Route 38, Mount Laurel, New Jersey 08054 Phone: (856) 235-7126 |